DiaMedica Therapeutics Inc (DMAC)
2.45
+0.03
(+1.24%)
USD |
NASDAQ |
Apr 24, 16:00
2.46
+0.01
(+0.41%)
After-Hours: 20:00
DiaMedica Therapeutics Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
September 30, 2018 | -277.4% |
June 30, 2018 | |
March 31, 2018 | |
December 31, 2017 | |
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2014 | |
September 30, 2014 | |
June 30, 2014 | |
March 31, 2014 | |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | |
September 30, 2012 |
Date | Value |
---|---|
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | |
September 30, 2011 | |
June 30, 2011 | |
March 31, 2011 | |
December 31, 2010 | |
September 30, 2010 | |
June 30, 2010 | |
March 31, 2010 | |
December 31, 2009 | |
September 30, 2009 | |
June 30, 2009 | |
March 31, 2009 | |
December 31, 2008 | |
September 30, 2008 | |
June 30, 2008 | |
March 31, 2008 | -604.5% |
December 31, 2007 | -1.70K% |
September 30, 2007 | -792.4% |
June 30, 2007 | -1.85K% |
March 31, 2007 | -2.57K% |
December 31, 2006 | |
September 30, 2006 | -2.55K% |
June 30, 2006 | -6.56K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
Nektar Therapeutics | -176.2% |
Marinus Pharmaceuticals Inc | -580.9% |
NextCure Inc | -- |
NovaBay Pharmaceuticals Inc | -110.2% |
Palatin Technologies Inc | -385.6% |